POSITIVE EFFECTS OF MODERN IMMUNOCORRECTION ACCORDING TO THE ANALYSIS OF CYTOKINES AND SLPI IN PATIENTS WITH PYELONEPHRITIS
The peculiarities of cytokines as compounds of immunogenesis are shown in the patients having acute (A) and chronic (Ch) pyelonephritis (PN). The combination of antibacterial therapy with Nukleinat and Galavit promotes the positive changes of cytokin-producing ability of immunocompetent cells and decrease in the level of proinflammation cytokines in blood and urine, secretory leucocyte protease inhibitor (SLPI) in urine. In children with PN and adult patients with diagnostically elevated titres of antibodies (IgG) to Herpes simplex virus, Cytomegalovirus are shown the positive effects of Kanephron® H and Proteflazidum, accordingly. Clinico-immunological effects of immunomodulators testify to the expediency of this usage in complex therapy with the aim to modulate the cytokine link of immunity for improvement of the effective treatment in APN and the protection against aggravation of kidney functioning in ChPN.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2014 |
|---|---|
| Enthalten in: |
Likars'ka sprava - (2014), 12 vom: 19. Dez., Seite 45-56 |
| Sprache: |
Ukrainisch |
|---|
| Beteiligte Personen: |
Driyanska, V E [VerfasserIn] |
|---|
| Anmerkungen: |
Date Completed 29.12.2015 Date Revised 06.10.2021 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM255300581 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM255300581 | ||
| 003 | DE-627 | ||
| 005 | 20231224174217.0 | ||
| 007 | tu | ||
| 008 | 231224s2014 xx ||||| 00| ||ukr c | ||
| 028 | 5 | 2 | |a pubmed24n0851.xml |
| 035 | |a (DE-627)NLM255300581 | ||
| 035 | |a (NLM)26638467 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ukr | ||
| 100 | 1 | |a Driyanska, V E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a POSITIVE EFFECTS OF MODERN IMMUNOCORRECTION ACCORDING TO THE ANALYSIS OF CYTOKINES AND SLPI IN PATIENTS WITH PYELONEPHRITIS |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 29.12.2015 | ||
| 500 | |a Date Revised 06.10.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The peculiarities of cytokines as compounds of immunogenesis are shown in the patients having acute (A) and chronic (Ch) pyelonephritis (PN). The combination of antibacterial therapy with Nukleinat and Galavit promotes the positive changes of cytokin-producing ability of immunocompetent cells and decrease in the level of proinflammation cytokines in blood and urine, secretory leucocyte protease inhibitor (SLPI) in urine. In children with PN and adult patients with diagnostically elevated titres of antibodies (IgG) to Herpes simplex virus, Cytomegalovirus are shown the positive effects of Kanephron® H and Proteflazidum, accordingly. Clinico-immunological effects of immunomodulators testify to the expediency of this usage in complex therapy with the aim to modulate the cytokine link of immunity for improvement of the effective treatment in APN and the protection against aggravation of kidney functioning in ChPN | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Antioxidants |2 NLM | |
| 650 | 7 | |a Cytokines |2 NLM | |
| 650 | 7 | |a Immunologic Factors |2 NLM | |
| 650 | 7 | |a Interferon Inducers |2 NLM | |
| 650 | 7 | |a Nucleic Acids |2 NLM | |
| 650 | 7 | |a Plant Preparations |2 NLM | |
| 650 | 7 | |a SLPI protein, human |2 NLM | |
| 650 | 7 | |a Secretory Leukocyte Peptidase Inhibitor |2 NLM | |
| 650 | 7 | |a kanefron H |2 NLM | |
| 650 | 7 | |a Luminol |2 NLM | |
| 650 | 7 | |a 5EXP385Q4F |2 NLM | |
| 650 | 7 | |a sodium nucleinate |2 NLM | |
| 650 | 7 | |a 9010-05-3 |2 NLM | |
| 650 | 7 | |a sodium luminolate |2 NLM | |
| 650 | 7 | |a KFG2PZR7UX |2 NLM | |
| 700 | 1 | |a Drannik, G N |e verfasserin |4 aut | |
| 700 | 1 | |a Stepanova, N M |e verfasserin |4 aut | |
| 700 | 1 | |a Lebed, L O |e verfasserin |4 aut | |
| 700 | 1 | |a Kruglikov, V T |e verfasserin |4 aut | |
| 700 | 1 | |a Driyanska, V V |e verfasserin |4 aut | |
| 700 | 1 | |a Lavrenchuk, O V |e verfasserin |4 aut | |
| 700 | 1 | |a Kalinina, N A |e verfasserin |4 aut | |
| 700 | 1 | |a Gaisenuk, F Z |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Likars'ka sprava |d 1996 |g (2014), 12 vom: 19. Dez., Seite 45-56 |w (DE-627)NLM012600008 |x 1019-5297 |7 nnns |
| 773 | 1 | 8 | |g year:2014 |g number:12 |g day:19 |g month:12 |g pages:45-56 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2014 |e 12 |b 19 |c 12 |h 45-56 | ||